Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Essex Bio-Technology (1061) Stock Price & Analysis

1 Followers

1061 Stock Chart & Stats

HK$2.04HK$0.04(2.00%)
At close: 4:00 PM GMT+8
HK$2HK$2.1HK$2.2HK$2.3Aug 17Aug 31Sep 14Sep 28Oct 12Oct 26Nov 9
Day’s Range
HKD 2.00 - HKD 2.04
52-Week Range
HKD 1.98 - HKD 4.56
Previous Close
HKD 2.00
Volume
N/A
Average Volume (3M)
126.39K
Market Cap
HKD 1.13B
Enterprise Value
HKD 1.06B
Total Cash (Recent Filing)
HKD 807.73M
Total Debt (Recent Filing)
HKD 348.99M
Price to Earnings (P/E)
4.3
Beta
0.23
Next Earnings
Mar 11, 2027 (Est.)
EPS Estimate
N/A
Last Dividend Ex-Date
Aug 18, 2026
Dividend Yield
5.88%

Bulls Say, Bears Say

Bulls Say

Integrated Ophthalmology Platform

Essex Bio-Technology spans product research, development, manufacturing, and commercialization in biologic ophthalmology. This integrated operating model can support control over product execution and market access, while specialization in eye-care therapies provides a focused platform for sustained development and sales.

High, Stable Profitability

Exceptionally high and stable gross margins, combined with solid EBIT margins, indicate that the company retains substantial economics after production costs. This profitability provides resources for ongoing product development and commercial activity, while offering resilience if revenue growth remains uneven.

Conservative Balance Sheet

Declining debt-to-equity and meaningful equity growth give Essex Bio-Technology a conservative financial structure. Consistently strong returns on equity also suggest effective capital use, supporting financial flexibility for reinvestment and helping the business absorb operating variability without relying heavily on leverage.

Bears Say

Choppy Revenue Performance

The uneven revenue pattern weakens confidence in the durability of recent commercial momentum. Declines across multiple periods and only a modest 2025 recovery make future growth less predictable, which could limit operating leverage and reduce the consistency of earnings expansion over the next several quarters.

Volatile Free Cash Flow

Positive operating cash flow supports underlying earnings quality, but the sharp 2025 free-cash-flow decline shows that cash conversion is not consistently translating into discretionary funds. Continued volatility could constrain reinvestment capacity and make shareholder returns less dependable across reporting periods.

Profitability Normalization

Although profitability remains healthy, net margin below the 2020–2021 peak indicates that prior earnings economics have not been fully maintained. Further normalization could reduce the benefit of strong gross margins and limit earnings growth unless revenue recovery becomes more consistent.

Essex Bio-Technology News

1061 FAQ

What was Essex Bio-Technology’s price range in the past 12 months?
Essex Bio-Technology lowest stock price was HK$1.98 and its highest was HK$4.56 in the past 12 months.
What is Essex Bio-Technology’s market cap?
Essex Bio-Technology’s market cap is HK$1.13B.
When is Essex Bio-Technology’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Essex Bio-Technology’s earnings last quarter?
Essex Bio-Technology released its earnings results on Aug 05, 2026. The company reported HK$0.195 earnings per share for the quarter.
Is Essex Bio-Technology overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Essex Bio-Technology pay dividends?
Essex Bio-Technology pays a semiannual dividend of HK$0.05 which represents an annual dividend yield of 5.88%. See more information on Essex Bio-Technology dividends here
What is Essex Bio-Technology’s EPS estimate?
Essex Bio-Technology’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Essex Bio-Technology have?
Essex Bio-Technology has 567,006,000 shares outstanding.
What happened to Essex Bio-Technology’s price movement after its last earnings report?
Essex Bio-Technology reported an EPS of HK$0.195 in its last earnings report. Following the earnings report the stock price went down -1.657%.
Which hedge fund is a major shareholder of Essex Bio-Technology?
Currently, no hedge funds are holding shares in HK:1061
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology